<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Moore MN</submitter><funding>NIDA NIH HHS</funding><pubmed_abstract>G protein-coupled receptors (GPCRs), the largest family of drug targets, can signal through 16 subtypes of Gα proteins. Biased compounds that selectively activate therapy-relevant pathways promise to be safer, more effective medications. The determinants of bias are poorly understood, however, and rationally-designed, G protein-subtype-selective compounds are lacking. Here, using the prototypical class A GPCR neurotensin receptor 1 (NTSR1), we find that small molecules binding the intracellular GPCR-transducer interface change G protein coupling by subtype-specific and predictable mechanisms, enabling rational drug design. We demonstrate that the compound SBI-553 switches NTSR1 G protein preference by acting both as a molecular bumper and a molecular glue. Structurally, SBI-553 occludes G </pubmed_abstract><journal>bioRxiv : the preprint server for biology</journal><pagination>2024.11.20.624209</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11601581</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Design of allosteric modulators that change GPCR G protein subtype selectivity.</pubmed_title><pmcid>PMC11601581</pmcid><funding_grant_id>R01 DA061773</funding_grant_id><funding_grant_id>UH3 DA050316</funding_grant_id><funding_grant_id>R00 DA048970</funding_grant_id><funding_grant_id>P30 DA048742</funding_grant_id><pubmed_authors>Person KL</pubmed_authors><pubmed_authors>Olson SH</pubmed_authors><pubmed_authors>Alwin A</pubmed_authors><pubmed_authors>Moore MN</pubmed_authors><pubmed_authors>Slosky LM</pubmed_authors><pubmed_authors>Foster N</pubmed_authors><pubmed_authors>Barak LS</pubmed_authors><pubmed_authors>Jackson MR</pubmed_authors><pubmed_authors>Fernandez de Velasco EM</pubmed_authors><pubmed_authors>Krusemark C</pubmed_authors><pubmed_authors>Inoue A</pubmed_authors><pubmed_authors>Sheedlo MJ</pubmed_authors><pubmed_authors>Ray C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Design of allosteric modulators that change GPCR G protein subtype selectivity.</name><description>G protein-coupled receptors (GPCRs), the largest family of drug targets, can signal through 16 subtypes of Gα proteins. Biased compounds that selectively activate therapy-relevant pathways promise to be safer, more effective medications. The determinants of bias are poorly understood, however, and rationally-designed, G protein-subtype-selective compounds are lacking. Here, using the prototypical class A GPCR neurotensin receptor 1 (NTSR1), we find that small molecules binding the intracellular GPCR-transducer interface change G protein coupling by subtype-specific and predictable mechanisms, enabling rational drug design. We demonstrate that the compound SBI-553 switches NTSR1 G protein preference by acting both as a molecular bumper and a molecular glue. Structurally, SBI-553 occludes G </description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Nov</publication><modification>2026-04-07T15:09:38.675Z</modification><creation>2026-04-07T14:24:01.49Z</creation></dates><accession>S-EPMC11601581</accession><cross_references><pubmed>39605353</pubmed><doi>10.1101/2024.11.20.624209</doi></cross_references></HashMap>